Diabetes Flashcards

1
Q

What happens to the incretic effect in T2D?

A

Reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GLP-1 analogs are contraindicated w/ family hx of what 3 disorders?

A
  1. TMC (Thyriod microcarcinoma)
  2. Pancreatitis
  3. Renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stable microtubules moved by dynein

A

Cilia and Flagella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Strong regulator of actin organization

A

Rho family GTPase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

secreted from ileum and colon, incretin, decrease, gastric emptying, glucogon decrease, improved cardiovascular risks

A

GLP-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Incretin effect

A

GI peptides that increase insulin senstivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In type 1D, Hypoglycemia-associated autonomic failure, increase in cortisol is induced by?

A

When glucagon response is lost, and epinephrine signaling is desensitized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is adherence important?

A

Extend quality of life,
Avoid complication (neuropathy, vision problems, organ failures),
Cost of non-adherence is high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors of nonadherence:

A
Patient family characteristics 
(SES and family composition 
Knowledge 
patient/family adjustment and coping),
Disease related characteristics,
Healthcare providers/ system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GLP-1 analagoues

A

Exanatide, Liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is GLP-1 analogues given?

A

Subcutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Interventions to improve adherence

A

Educational,
Organisational
Behavioural

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cAMP increases due to signaling molecules

A

Glucagon and epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PFK-1 Is inhibited by

A

ATP and citrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PFK-1 is activated by

A

AMP, fructose 2,6 Bis-P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is glycogen synthase inactivated? and glycogen phosphorylase activated

A

Phosphorylation from Protein Kinase A (G-protein signaling pathway, activated by cAMP)

17
Q

What does Protein Kinase A activate

A

Glycogen phosphorylase and synthase in liver, and R-domain in CFTR

18
Q

How is glycogen used?

A

phosphorylated to Glucose-1-phosphate

19
Q

What does glucagon do in gene expression levels?

A

Glucagon induced expression of phosphoenolpyruvate carboxykinase

20
Q

eg. of compartmentation of metabolic activities

A

transport fatty acid to mitochondria for beta oxidation and synthesis takes place in cytoplasm

21
Q

Secondary messengars of catecholamines

A

cAMP and Calcium

22
Q

How is catecholamines secreted

A

sympathetic nervous system–> adrenal gland–> catecholamines–> secondary messengers—-> acute response

23
Q

Example of catecholamines

A

epinephrine and norepinephrine

24
Q

Effect of catecholamines

A

Lungs: more oxygen,
Adipose: Free fatty acid,
Liver: Glycogen breakdown,
muscle : ATP production for movement from Free FA and glucose

25
What does insulin activate in liver?
Protein Phosphatase
26
Hyperpigmented, velvety plaques in folds, accutane | Color due to keratin-containing superficial epithelium
Acanthosis Nigiricans
27
What helps Acanthosis Nigiricans? Reduce the lesions and decrease order and provide comfort
Salicylic acid or retinoic acid
28
Exenatide
Ala---> Gly Renal CL and although good effects as gastric empting and glucose-dependent insulin and glucagon secretion, Risk of Pancreatis and thyroid cancer
29
How are GLP-1 analogue given?
Subcutaneous injection
30
What is the modification of Liraglutide?
Arg 34 Lys | Lys 26 Glu with C-16 FA chain
31
DPP-4i
Viladagliptin and sitagliptin orally no gastic emptying risk of pancreatitis and infection